Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) just unveiled an announcement.
Shandong Weigao Group Medical Polymer Co., Ltd. has announced an extraordinary general meeting to discuss the approval and adoption of the 2025 H Share Incentive Scheme, which aims to grant share awards and manage the issuance of shares up to 4.5% of the company’s total shares. Additionally, the company plans to distribute an interim dividend and reappoint Mrs. Meng Hong as an independent non-executive director, reflecting its commitment to shareholder value and governance.
The most recent analyst rating on (HK:1066) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Co., Ltd. is a company incorporated in the People’s Republic of China, focusing on the medical polymer industry. It is involved in the production and distribution of medical devices and related products.
Average Trading Volume: 14,960,364
Technical Sentiment Signal: Hold
Current Market Cap: HK$26.27B
For detailed information about 1066 stock, go to TipRanks’ Stock Analysis page.